In the same treatment groups, we evaluated the expression of the Ad E1A (35–46 kDa), a key component of Ad replication machinery [25], as well as the expression of SA-4-1BBL (37 kDa) in both lung cancer cell lines. This evidence concerns the gene DHTKD1 and lung cancer.